Immunogenicity of Plasmodium falciparum and Plasmodium vivax circumsporozoite protein repeat multiple antigen constructs (MAC)

By Udhayakumar V.   Saekhou A.   Fang S.   Jue D.   Wohlhueter R.M.   Lal A.A.  

Vaccine, Vol. 16, Iss. 9, 1998-05 ,pp. : 982-988

Elsevier

Access to resources Recommend Favorite

Production of recombinant SERA proteins of Plasmodium falciparum in Escherichia coli by using synthetic genes

By Sugiyama T.   Suzue K.   Okamoto M.   Inselburg J.   Tai K.   Horii T.  

Vaccine, Vol. 14, Iss. 11, 1996-08 ,pp. : 1069-1076

Elsevier

Access to resources Recommend Favorite

Plasmodium falciparum acid basic repeat antigen (ABRA) peptides: erythrocyte binding and biological activity

By Curtidor H.   Urquiza M.   Suarez J.E.   Rodriguez L.E.   Ocampo M.   Puentes A.   Garcia J.E.   Vera R.   Lopez R.   Ramirez L.E.   Pinzon M.   Patarroyo M.E.  

Vaccine, Vol. 19, Iss. 31, 2001-08 ,pp. : 4496-4504

Elsevier

Access to resources Recommend Favorite

Strategy for development of a pre-erythrocytic Plasmodium falciparum DNA vaccine for human use

By Hoffman S.L.   Doolan D.L.   Sedegah M.   Aguiar J.C.   Wang R.   Malik A.   Gramzinski R.A.   Weiss W.R.   Hobart P.   Norman J.A.   Margalith M.   Hedstrom R.C.  

Vaccine, Vol. 15, Iss. 8, 1997-06 ,pp. : 842-845

Elsevier

Access to resources Recommend Favorite

Immune response induced by recombinant BCG expressing merozoite surface antigen 2 from Plasmodium falciparum

By Zheng C.   Xie P.   Chen Y.  

Vaccine, Vol. 20, Iss. 5, 2001-12 ,pp. : 914-919

Elsevier

Access to resources Recommend Favorite